RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

No results found for given criteria.

Related Reports

Market Research Reports provided by reports.iptechex.com
Failure of TAK442 to Meet the Primary End-point in a Phase II Study Underlines the Challenging Clinical Development Environment for Anticoagulants in Acute Coronary Syndromes
Nov 2010 - 5 pages - $500
Acute Coronary Syndromes Therapy Area Pipeline Report
Nov 2010 - 329 pages - $1,495
Acute Coronary Syndromes - Pipeline Review, Q1 2011
Feb 2011 - 62 pages - $500
Acute Heart Failure - Pipeline Review, Q1 2011
Feb 2011 - 29 pages - $500
Acute Heart Failure - Pipeline Review, H2 2011
Sep 2011 - 58 pages - $500
Acute Heart Failure - Pipeline Assessment and Market Forecasts to 2017
Dec 2010 - 47 pages - $2,000
Congestive Heart Failure Therapy Area Pipeline Report
Nov 2010 - 539 pages - $1,495
The Cardiovascular Market Outlook to 2016
Jun 2011 - 160 pages - $3,835
Acute Coronary Syndrome - Pipeline Review, H2 2011
Sep 2011 - 106 pages - $500
Acute Renal Failure (ARF) - Pipeline Review, Q4 2010
Dec 2010 - 68 pages - $500
More Related Market Research Reports >>>

Your selection

Industry sector
Drug discovery del
Drug research platforms del
Therapeutic target
Cardiovascular del
Acute coronary syndromes del
Heart failure del
Development phase
Phase III del

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us